Cite
HARVARD Citation
Lalezari, S. et al. (2019). BAY 94‐9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results. Haemophilia. 25 (6), pp. 1011-1019. [Online].